✦ LIBER ✦

Potential biomarkers of bortezomib activity in mantle cell lymphoma from the phase 2 PINNACLE trial

✍ Scribed by Goy, André; Bernstein, Steven H.; Mcdonald, Alice; Pickard, Michael D.; Shi, Hongliang; Fleming, Mark D.; Bryant, Barb; Trepicchio, William; Fisher, Richard I.; Boral, Anthony L.; Mulligan, George

Book ID: 126166043
Publisher: Informa plc
Year: 2010
Tongue: English
Weight: 491 KB
Volume: 51
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2010.483302

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 trial of rituximab and bortezomi

Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphoma

✍ Robert A. Baiocchi; Lapo Alinari; Mark E. Lustberg; Thomas S. Lin; Pierluigi Por 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 1 views

Potential efficacy of the oral histone d

Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma

✍ Takashi Watanabe; Harumi Kato; Yukio Kobayashi; Satoshi Yamasaki; Yuriko Morita- 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB

Efficacy and toxicity of 2 schedules of

Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma : A randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA)

✍ Vincent Ribrag; Christian Gisselbrecht; Corinne Haioun; Gilles Salles; Jean-Bapt 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

CHOP and DHAP plus rituximab followed by

CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte

✍ Delarue, Richard (author);Haioun, Corinne (author);Ribrag, Vincent (author);Bric 📂 Article 📅 2013 🏛 American Society of Hematology 🌐 English ⚖ 319 KB

CHOP and DHAP plus rituximab followed by

CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte

✍ Delarue, Richard (author);Haioun, Corinne (author);Ribrag, Vincent (author);Bric 📂 Article 📅 2013 🏛 American Society of Hematology 🌐 English ⚖ 319 KB